Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

23458-04-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one

    Cas No: 23458-04-0

  • No Data

  • No Data

  • No Data

  • Reading Reagent
  • Contact Supplier
  • 23458-04-0 Structure
  • Basic information

    1. Product Name: (9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one
    2. Synonyms: (-)-trans-Khellactone;(9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one;[9R,10S,(-)]-9,10-Dihydro-9,10-dihydroxy-8,8-dimethyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one;9,10-Dihydro-9α,10β-dihydroxy-8,8-dimethyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one
    3. CAS NO:23458-04-0
    4. Molecular Formula: C14H14O5
    5. Molecular Weight: 262.25796
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 23458-04-0.mol
  • Chemical Properties

    1. Melting Point: 184.5-186.0℃
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: (9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one(CAS DataBase Reference)
    10. NIST Chemistry Reference: (9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one(23458-04-0)
    11. EPA Substance Registry System: (9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one(23458-04-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 23458-04-0(Hazardous Substances Data)

23458-04-0 Usage

Uses

Used in Pharmaceutical Research:
(9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one is used as a pharmaceutical candidate for its potential health benefits and antioxidant properties. Its unique chemical structure and bioactivity make it an interesting compound for the development of new drugs and therapeutic agents.
Used in Natural Product Chemistry:
In the field of natural product chemistry, (9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one is used for studying the chemical properties and interactions of dimeric isoflavones. Its unique structure and functional groups provide insights into the synthesis and modification of similar compounds for various applications.
Used in Biochemistry:
(9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one is utilized in biochemistry for understanding its interactions with biological systems. Its antioxidant properties and potential health benefits make it a valuable compound for studying its effects on cellular processes and mechanisms.
Used in Antioxidant Applications:
In antioxidant applications, (9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one is used for its ability to neutralize free radicals and protect cells from oxidative damage. Its presence in plants and potential health benefits make it a promising candidate for developing antioxidant supplements and functional foods.
Used in Cosmetics Industry:
In the cosmetics industry, (9R)-8,8-Dimethyl-9α,10β-dihydroxy-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one is used as an active ingredient for its antioxidant and skin-protective properties. Its potential health benefits and ability to neutralize free radicals make it a valuable component in skincare products, promoting skin health and reducing the signs of aging.

Check Digit Verification of cas no

The CAS Registry Mumber 23458-04-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,4,5 and 8 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 23458-04:
(7*2)+(6*3)+(5*4)+(4*5)+(3*8)+(2*0)+(1*4)=100
100 % 10 = 0
So 23458-04-0 is a valid CAS Registry Number.

23458-04-0Relevant articles and documents

Chromones and coumarins from Saposhnikovia divaricata (Turcz.) Schischk. Growing in Buryatia and Mongolia and their cytotoxicity

Frolova, Tatyana S.,Ganbaatar, Jamsranjav,Petrova, Tatyana N.,Pokrovskii, Andrey G.,Radnaeva, Larisa D.,Rybalova, Tatyana V.,Shults, Elvira E.,Taraskin, Vasilii V.,Urbagarova, Bayarma M.

, (2020/07/23)

Ethnopharmacological relevance: Saposhnikovia divaricata (family Apiaceae) a traditional medicinal plant distributed in many provinces of China, is well known for the pharmaceutical value and has been used for rheumatic arthritis, and anxiety in children. Antiviral, antioxidant and antiproliferative activities were also mentioned. The application of this plant are recorded in the Chinese Medicine (CM) classical text the Shen Nong's Materia Medica (Shen Nong Ben Cao Jing). In this monograph S. divaricata (syn Radix Ledebouriella divaricata) is graded as a premium-grade herb, with their broad-spectrum of therapeutic applications for the treatment of cough, common cold, arthralgia, as well as in rheumatic disorders. Aim of the study: To isolate and identify chemical constituents (chromones and coumarins) from S. divaricata, collected in Buryatia and Mongolia and to study their in vitro anticancer activity against MEL-8, U-937, DU-145, MDA-MB-231 and ВТ-474 cell lines. Materials and methods: An 40% aqueous ethanol extract of the roots of S. divaricata was prepared and further successively fractionated by extraction with petroleum ether, diethyl ether, tert-butyl methyl ether and ethyl acetate. The obtained extracts were subjected to a series of chromatographic separations on silica gel for isolation of individual compounds. Isolated compounds were tested for their cytotoxicity with respect to model cancer cell lines using the conventional MTT assays. Results: Total of 15 individual compounds: coumarins scopoletin 2, bergapten 3, isoimperatorin 4, marmesin 5, (+)-decursinol 9, (?)-praeruptorin B 10, oxypeucedanin hydrate 11, chromones: hamaudol 6, cimifugin 7, 5-О-methylvisamminol 8, chromone glycosides: prim-O-glucosylcimifugin 12, sec-O-glucosylhamaudol 13, 4′-O-β-D-glucopyranosyl-5-О-methylvisamminol 14, 4′-O-β-D-glucopyranosylvisamminol (15) and also polyyne compound panaxinol 1 were isolated and characterized. The structure of dihydropyranocoumarin 10 was confirmed by X-ray diffraction analyses. HPLC-UV method was used for determination of the content of most abundant chromones 7, 12 and 14 in the roots of S. divaricata, collected in Mongolia. Compounds 3–11 and 13, 14 were evaluated for their cytotoxicity with respect to model cancer cell lines. All the compounds were non-toxic in the hemolysis test. Conclusion: This report about the phytochemical profiles of S. divaricata growing in Mongolia and Buryatia led to the identification of 14 compounds including coumarins and chromones. The available coumarins and chromones may serve as new leads for the discovery of anticancer drugs.

Therapeutic evaluation of synthetic peucedanocoumarin III in an animal model of Parkinson’s disease

Ham, Sangwoo,Kim, Heejeong,Yoon, Jin-Ha,Kim, Hyojung,Song, Bo Reum,Choi, Jeong-Yun,Lee, Yun-Song,Paek, Seung-Mann,Maeng, Han-Joo,Lee, Yunjong

, (2019/11/13)

The motor and nonmotor symptoms of Parkinson’s disease (PD) correlate with the formation and propagation of aberrant α-synuclein aggregation. This protein accumulation is a pathological hallmark of the disease. Our group recently showed that peucedanocoumarin III (PCIII) possesses the ability to disaggregate β sheet aggregate structures, including α-synuclein fibrils. This finding suggests that PCIII could be a therapeutic lead compound in PD treatment. However, the translational value of PCIII and its safety information have never been explored in relevant animal models of PD. Therefore, we first designed and validated a sequence of chemical reactions for the large scale organic synthesis of pure PCIII in a racemic mixture. The synthetic PCIII racemate facilitated clearance of repeated β sheet aggregate (β23), and prevented β23-induced cell toxicity to a similar extent to that of purified PCIII. Given these properties, the synthetic PCIII’s neuroprotective function was assessed in 6-hydroxydopamine (6-OHDA)-induced PD mouse models. The PCIII treatment (1 mg/kg/day) in a 6-OHDA-induced PD mouse model markedly suppressed Lewy-like inclusions and prevented dopaminergic neuron loss. To evaluate the safety profiles of PCIII, high dose PCIII (10 mg/kg/day) was administered intraperitoneally to two-month-old mice. Following 7 days of PCIII treatment, PCIII distributed to various tissues, with substantial penetration into brains. The mice that were treated with high dose PCIII had no structural abnormalities in the major organs or neuroinflammation. In addition, high dose PCIII (10 mg/kg/day) in mice had no adverse impact on motor function. These findings suggest that PCIII has a relatively high therapeutic index. Given the favorable safety features of PCIII and neuroprotective function in the PD mouse model, it may become a promising disease-modifying therapy in PD to regulate pathogenic α-synuclein aggregation.

ISOSAMIDIN ANALOG AND SAMIDIN ANALOG PRODUCTION METHOD

-

, (2018/10/19)

PROBLEM TO BE SOLVED: To provide a simple method of industrial-scale production of an isosamidin analog or samidin analog. SOLUTION: In the production method, a compound represented by the formula (1) in the figure is 1) senecioylated and 2) acetylated. [X is O or the like; R1 are each independently a C1-3 alkyl group or the like; R2 is H or the like; R3 are each a C1-3 alkyl group; m is an integer from 0 to 2; n is 1 or 2; and the symbol * represents an asymmetric center.] SELECTED DRAWING: None COPYRIGHT: (C)2018,JPOandINPIT

Determination of the Absolute Configuration of Khellactone Esters from Peucedanum japonicum Roots

Hong, Min Jee,Kim, Jinwoong

, p. 1354 - 1360 (2017/06/01)

Sixteen new angular dihydropyranocoumarins (1-16) and 24 known compounds were isolated from the roots of Peucedanum japonicum Thunb. The absolute configuration of diacylkhellactone was established by partial hydrolysis, the Mosher method, and X-ray crysta

Antidiabetic effect, antioxidant activity, and toxicity of 3′,4′-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats

Domínguez-Mendoza, Elix Alberto,Cornejo-Garrido, Jorge,Burgue?o-Tapia, Eleuterio,Ordaz-Pichardo, Cynthia

supporting information, p. 4086 - 4091 (2016/08/01)

Pyranocoumarins are compounds with an important pharmacological profile, such as anti-inflammatory, antioxidant, cytotoxic, antiviral, antibacterial, and hypoglycemic effects. These molecules have a widespread presence as secondary metabolites in medicinal plants used to treat Diabetes Mellitus (DM). The aim of this work was to evaluate antidiabetic activity in Streptozotocin (STZ)-induced diabetic rats and the antioxidant effects of 3′,4′-Di-O-acetyl-cis-khellactone (DOAcK), as well as its toxic potential. We obtained DOAcK with an enantiomeric excess of 70% by chemical synthesis. Our results showed that this compound exerts an important antidiabetic effect: blood glucose decreased in groups treated with DOAcK by 60.9% at dose of 15?mg/kg (p?50) >2000?mg/kg and, at this dose, no signs of toxicity or death were reported after 14?days of observation. These results indicate that DOAcK can improve glucose metabolism, which may be due to the increased antioxidant activity of CAT, GPx and SOD. In addition, DOAcK is not toxic in the studies tested.

Improved Biological Activities of Isoepoxypteryxin by Biotransformation

Mira, Amira,Amen, Yhiya M.,Alkhiary, Wael,Zhu, Qinchang,Nakagawa, Toshinori,Tran, Hai-Bang,Shimizu, Kuniyoshi

, p. 1307 - 1315 (2016/12/21)

Isoepoxypteryxin is the major coumarin of a Japanese medicinal plant Angelica shikokiana. This research was designed to study the effect of structural changes through fungal biotransformation on the reported biological activities of isoepoxypteryxin. Among the tested microorganisms, only Cordyceps sinensis had enzymes that could catalyze the ester hydrolysis and the reductive cleavage of the epoxide ring of isoepoxypteryxin, separately, to give two more polar metabolites (+)-cis-khellactone (P1) and a new coumarin derivative (+)-cis-3′-[(2-methyl-3-hydroxybutanoyl)oxy]-4′-acetoxy-3′,4′-dihydroseselin (P2), respectively. The polar metabolite P2 showed stronger cytotoxicity and higher selectivity than isoepoxypteryxin. On the molecular level, P2 showed more in vitro inhibition of both tubulin polymerization and histone deacetylase 8 (HDAC8). Similarly, P2 showed more neuroprotection against amyloid beta fragment 1 – 42 (Aβ1 – 42)-induced neurotoxicity in human neuroblastoma cells (SH-SY5Y) and exhibited more inhibition of the in vitro aggregation of Aβ1 – 42. Both metabolites showed stronger antiplatelet aggregation by increased inhibition of thromboxane-A2 synthase (TXS) activity and thromboxane-A2 (TXA2) production. This study is the first to describe the improved cytotoxic, neuroprotective, and antiplatelet aggregation activities of isoepoxypteryxin through its biotransformation by C. sinensis.

Towards heterogeneous organocatalysis: Chiral iminium cations supported on porous materials for enantioselective alkene epoxidation

Bulman Page, Philip C.,Mace, Andrew,Arquier, Damien,Bethell, Donald,Buckley, Benjamin R.,Willock, David J.,Hutchings, Graham J.

, p. 2330 - 2339 (2013/09/02)

Enantiomerically pure iminium cations have been supported on a microporous support (zeolite Y) and on a mesoporous support (Al-MCM-41). These materials are effective asymmetric catalysts for the epoxidation of a range of aryl alkenes, giving high conversions quickly and with enantioselectivities similar to or in some cases even higher than are achievable using the corresponding iminium tetraphenylborates under homogeneous conditions. The catalysts can be simply recycled by filtration and washing. The methodology is illustrated in the synthesis of two natural products, (-)-(3′S)-lomatin and (+)-(3′S,4′R)-trans-khellactone, showing the general efficacy of our approach. The Royal Society of Chemistry 2013.

Enantioseparation and absolute configuration determination of angular-type pyranocoumarins from Peucedani radix using enzymatic hydrolysis and chiral HPLC-MS/MS analysis

Song, Yue-Lin,Zhang, Qing-Wen,Li, Ya-Ping,Yan, Ru,Wang, Yi-Tao

experimental part, p. 4236 - 4251 (2012/07/27)

Angular-type pyranocoumarins from Peucedani Radix (Chinese name: Qian-hu) have exhibited potential for use on treatment of cancer and pulmonary hypertension. Due to the existence of C-3′ and C-4′ chiral centers, compounds belonging to this chemical type commonly exist in enantiomers and/or diastereoisomers, which may elicit distinct activities during their interactions with the human body. In the present study, a new method, which combines enzymatic hydrolysis with chiral LC-MS/MS analysis, has been developed to determine the absolute configurations of these angular-type pyranocoumarins. Pyranocoumarins isolated from Qian-hu, their enantiomers, or metabolites were individually incubated with rat liver microsomes. As the common end product from enzymatic hydrolysis of all tested pyranocoumarins, cis-khellactone was collected and its absolute configuration was determined by comparison with (+)-cis-khellactone and (-)-cis-khellactone using chiral LC-MS/MS. The absolute configurations of all tested parent pyranocoumarins were determined by combination of LC-MS/MS, NMR and polarimetric analysis. The results revealed that the metabolite cis-khellactone retained the same absolute configurations of the stereogenic carbons as the respective parent compound. This method was proven to be rapid and sensitive and also has advantages in discriminating single enantiomers and mixtures of optical isomers with different ratios.

3′-O, 4′-O-aromatic acyl substituted 7,8-pyranocoumarins: A new class of P-glycoprotein modulators

Shen, Xiaoling,Chen, Guangying,Zhu, Guoyuan,Cai, Jiazhong,Wang, Lu,Hu, Yingjie,Fong, Wang-Fun

experimental part, p. 90 - 100 (2012/07/01)

Objectives P-glycoprotein (Pgp) overexpression in tumour cells leads to multidrug resistance (MDR) and causes failure in cancer chemotherapy. We have previously identified (±)-praeruptorin A (PA) as a potential lead compound for Pgp modulators. In this study we investigated the MDR-reversing activities of PA derivatives. Methods Series 7,8-pyranocoumarins with various C-3′ and C-4′ side chains had been semi-synthesized and their MDR-reversing activity was investigated in Pgp-overexpressing MDR tumour cell line HepG2/Dox and in a KB V1 xenograft animal model. Key findings All 7,8-pyranocoumarins exhibited equal or higher activity in modulating Pgp. DCK (12), DMDCK (15), 16, 21, 23 and 24 at 4 μm achieved 91%~99% decrease in IC50 value (concentration inhibiting cell growth by 50%) of anticancer agents vinblastine, doxorubicin, puromycin and paclitaxel, and were more active than others. DMDCK also remarkably enhanced the growth inhibitory effect of paclitaxel on KB V1 xenografts (P 0.05), showing a potency required for clinical usage. Mechanistic studies suggested that these 7,8-pyranocoumarins might reverse Pgp-MDR through directly binding to substrate binding site(s) or allosteric site(s) on Pgp therefore impairing Pgp-mediated drug transport. Conclusions Results from the study suggested that 3′-O, 4′-O-aromatic acyl substituted 7,8-pyranocoumarins could serve as a new class of Pgp modulator. Acyls play an important role in maintaining and enhancing the Pgp-modulating ability of pyranocoumarins. 3,4-Dimethoxyl substituted aromatic acyls, bearing a methoxy that might interact with Pgp as hydrogen bond accepter, were shown to be the most potent for reversing MDR. 2011 The Authors. JPP

Characterization of metabolism of (+)-praeruptorin B and (+)-praeruptorin E in human and rat liver microsomes by liquid chromatography coupled with ion trap mass spectrometry and time-of-flight mass spectrometry

Song, Yue-Lin,Yan, Ru,Jing, Wang-Hui,Zhao, Hai-Yu,Wang, Yi-Tao

experimental part, p. 719 - 730 (2012/02/02)

Peucedani Radix is a Chinese medicinal herb noted for its effects on treatments of respiratory and pulmonary disorders. As a part of a systematic pharmacokinetic evaluation of the herb in our laboratory, the present study investigated, for the first time, the metabolic profile of (+)-praeruptorin B (dPB) and (+)-praeruptorin E (dPE), two main bioactive constituents of Peucedani Radix in pooled liver microsomes of rats (RLMs) and humans (HLMs). dPE was eliminated faster than dPB in both species. The incubation of dPB with RLMs and HLMs resulted in eight (B1-B8) and nine (B1-B9) metabolites, respectively, while both RLMs and HLMs converted dPE into 13 metabolites (E1-13). Structures of all the metabolites were proposed through comparing their mass data obtained via tandem mass spectrometry on an MSD ion trap system (IT-MS/MS) coupled with high-resolution mass measurement by time-of-flight mass spectrometry (TOF-MS) with those of the respective parent compound. B1 and E1 were unambiguously identified as (-)-cis-khellactone. The formations of all the metabolites were NADPH-dependent. Oxidation and hydrolysis were demonstrated to be two predominant metabolic pathways of dPB and dPE. Oxidation initiated at either the C-3′ or C-4′ substituent, while hydrolysis only started from the C-3′ substituent. Fragmentation of all metabolites followed similar pathways to those of the parent pyranocoumarins. The information on metabolic properties of dPB and dPE and the mass fragmentation profiles of their metabolites obtained in the present study will aid in characterization of metabolic profiles of other angular-type pyranocoumarins and further investigation of in vivo fates of these pyranocoumarins and the herb. Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23458-04-0